Frey, A.; Martin, D.; D’Cruz, L.; Fokas, E.; Rödel, C.; Fleischmann, M.
C-Reactive Protein to Albumin Ratio as Prognostic Marker in Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy. Biomedicines 2022, 10, 598.
https://doi.org/10.3390/biomedicines10030598
AMA Style
Frey A, Martin D, D’Cruz L, Fokas E, Rödel C, Fleischmann M.
C-Reactive Protein to Albumin Ratio as Prognostic Marker in Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy. Biomedicines. 2022; 10(3):598.
https://doi.org/10.3390/biomedicines10030598
Chicago/Turabian Style
Frey, Alina, Daniel Martin, Louisa D’Cruz, Emmanouil Fokas, Claus Rödel, and Maximilian Fleischmann.
2022. "C-Reactive Protein to Albumin Ratio as Prognostic Marker in Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy" Biomedicines 10, no. 3: 598.
https://doi.org/10.3390/biomedicines10030598
APA Style
Frey, A., Martin, D., D’Cruz, L., Fokas, E., Rödel, C., & Fleischmann, M.
(2022). C-Reactive Protein to Albumin Ratio as Prognostic Marker in Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy. Biomedicines, 10(3), 598.
https://doi.org/10.3390/biomedicines10030598